12:00 AM
Jan 04, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

4SC-205: Phase I started

4SC began an open-label, dose-escalation, German Phase I trial to evaluate oral 4SC-205 in up to...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >